Amitriptyline for fibromyalgia in adults-Reference-Cited by-同舟云学术

Amitriptyline for fibromyalgia in adults

Published:2015-07-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Moore R Andrew¹,Derry Sheena²,Aldington Dominic³,Cole Peter⁴,Wiffen Philip J⁵

Affiliation:

1. Plymouth UK

2. Oxford Oxfordshire UK

3. Royal Hampshire County Hospital; Winchester UK SO22 5DG

4. Churchill Hospital, Oxford University Hospitals NHS Trust; Oxford Pain Relief Unit; Old Road Headington Oxford UK OX3 7LE

5. Thame UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference79 articles.

1. Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial;Braz;Revista Brasileira de Psiquiatria,2013

2. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study;Carette;Arthritis and Rheumatism,1986

3. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial;Carette;Arthritis and Rheumatism,1994

4. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia;Carette;Arthritis and Rheumatism,1995

5. Cauma W (Principle investigator) Immune-Pineal Axis Function in Fibromyalgia www.clinicaltrials.gov/ct2/show/NCT02041455?term=NCT02041455&rank=1 (accessed 30 Mar 15) 2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic advances in fibromyalgia: what’s new on the horizon?;Expert Opinion on Pharmacotherapy;2024-05-23

2. The impact of Yoga on patients with knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials;PLOS ONE;2024-05-16

3. Low-dose Naltrexone Improves post–COVID-19 condition Symptoms;Clinical Therapeutics;2024-03

4. How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) – A pharmacological review;Joint Bone Spine;2024-01

5. Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study;Breast Care;2024